دورية أكاديمية

Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma

التفاصيل البيبلوغرافية
العنوان: Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma
المؤلفون: Dave, Hema, Terpilowski, Madeline, Mai, Mimi, Toner, Keri, Grant, Melanie, Stanojevic, Maja, Lazarski, Christopher, Shibli, Abeer, Bien, Stephanie A., Maglo, Philip, Hoq, Fahmida, Schore, Reuven, Glenn, Martha, Hu, Boyu, Hanley, Patrick J., Ambinder, Richard, Bollard, Catherine M. *
المصدر: In Blood Advances 25 January 2022 6(2):473-485
قاعدة البيانات: ScienceDirect
الوصف
تدمد:24739529
DOI:10.1182/bloodadvances.2021005343